Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
45.46
+0.85 (1.91%)
At close: Jul 1, 2026, 4:00 PM EDT
46.21
+0.75 (1.65%)
After-hours: Jul 1, 2026, 7:53 PM EDT

Inspire Medical Systems Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $51.77. The average 1-year stock price forecast is 13.88% higher than the current stock price, while the lowest is $39 (-14.21%) and the highest is $65 (+42.98%).

Price Target: $51.77 (+13.88%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$39$51.77$52$65
Change-14.21%+13.88%+14.39%+42.98%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy744433
Buy111100
Hold91210101112
Sell000011
Strong Sell000000
Total171715151516

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Evercore ISI
Evercore ISI
Hold
Downgrades
$55$40
HoldDowngrades$55$40-12.01%Jun 23, 2026
Bank of America Securities
Bank of America Securities
Sell
Downgrades
$53$39
SellDowngrades$53$39-14.21%May 22, 2026
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 7, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$70$56
HoldMaintains$70$56+23.19%May 6, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
$67$54
HoldMaintains$67$54+18.79%May 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
843.24M
from 911.98M
Decreased by -7.54%
Revenue Next Year
876.02M
from 843.24M
Increased by 3.89%
EPS This Year
0.90
from 2.42
Decreased by -62.86%
EPS Next Year
1.29
from 0.90
Increased by 43.86%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
233.39M407.86M624.80M802.80M911.98M843.24M
Revenue Growth
102.28%74.75%53.19%28.49%13.60%-7.54%
Gross Profit
200.12M341.74M528.22M679.82M778.76M725.74M
Gross Margin
85.74%83.79%84.54%84.68%85.39%86.07%
Operating Income
-39.85M-47.59M-40.27M36.08M50.95M20.54M
Net Income
-42.04M-44.88M-21.15M53.51M145.42M13.63M
EPS
----2.420.90
EPS Growth
----38.29%-62.86%
Forward PE
---114.3757.1450.58
Free Cash Flow
-10.69M17.43M27.63K62.72M54.50M117.60M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High852.4M
Avg843.2M
Low826.0M

Revenue Growth

Revenue Growth202620272028
High
-6.5%
Avg
-7.5%
Low
-9.4%

EPS Forecast

EPS202620272028
High1.00
Avg0.90
Low0.79

EPS Growth

EPS Growth202620272028
High
-58.7%
Avg
-62.9%
Low
-67.4%